Skip to main content

Learn how Lilli Health is shaping the future of PCOS wellness. Learn More



Understanding GLP1 Agonists for PCOS: What You Need to Know Before Trying

Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder that affects many aspects of a woman’s health, including fertility, metabolism, and overall well-being. For individuals with PCOS considering treatment options, one potential avenue that healthcare providers may suggest is using GLP1 agonists. These medications have garnered attention for their ability to lower blood sugar levels and promote weight loss. However, it’s essential to understand how these drugs work, their potential long-term effects, and the importance of lifestyle modifications in conjunction with medication therapy.  

How GLP1 Agonists Work

GLP1 agonists are a class of medications that mimic the action of a hormone called glucagon-like peptide 1 (GLP-1). These medications work by stimulating insulin secretion from the pancreas, which helps lower blood sugar levels. Additionally, GLP1 agonists slow down the rate at which food moves through the stomach, leading to a feeling of fullness and reduced appetite.  

For many individuals with PCOS who struggle with insulin resistance and weight management, GLP1 agonists can offer significant short-term benefits. These may include improved blood sugar control, weight loss, and reduced appetite. However, it’s essential to recognize that these medications do not address the underlying causes of insulin resistance and metabolic dysfunction in PCOS.  

While GLP1 agonists can provide valuable support in managing PCOS symptoms, there are potential long-term considerations that patients should be aware of. One concern is the sustained stimulation of insulin secretion from the pancreas. Over time, this continuous demand on the pancreas may contribute to worsening insulin resistance and pancreatic insufficiency later in life. While the long-term consequences of GLP1 agonists remain unknown, it is well recognized that sustained pancreatic overstimulation can lead to worsening insulin resistance and, ultimately, a point where the pancreas no longer secretes insulin, potentially leading to the development of type 2 diabetes.   

“The road to diabetes and blood sugar management is not one where you force the pancreas to secrete more insulin; rather, it involves dietary modifications that lead to less glucose in the bloodstream, such as the elimination of starches and sugars from the diet.”  

The Role of Lifestyle Modifications

In light of the potential concerns surrounding long-term medication use, patients undergoing treatment with GLP1 agonists should prioritize lifestyle modifications to support their overall health and well-being. Adopting a Low Insulin Lifestyle, characterized by dietary choices that minimize insulin spikes, can help alleviate the burden on the pancreas and promote metabolic health.  

Patients undergoing treatment with GLP1 agonists can use this time of reduced appetite and potential weight loss to solidify positive lifestyle changes. By embracing a Low Insulin Lifestyle and incorporating regular physical activity, individuals can optimize the benefits of medication therapy and minimize the risk of weight regain upon discontinuation.    


In conclusion, while GLP1 agonists offer promising benefits for individuals with PCOS, especially those grappling with insulin resistance and weight management challenges, it’s imperative for patients to grasp the potential ramifications of prolonged medication use. Understanding the long-term effects, including the risk of exacerbating insulin resistance and pancreatic dysfunction, underscores the importance of adopting a comprehensive approach to health management.  

In combination with medication therapy, prioritizing lifestyle modifications is of the utmost importance. A cornerstone of this approach is the adoption of a Low Insulin Lifestyle, which has demonstrated efficacy in lowering insulin levels across multiple clinical studies, including a rigorous randomized controlled trial. This evidence-based approach focuses on minimizing insulin spikes by eliminating insulin spiking foods such as starches, certain types of dairy foods, and sugars from the diet. By embracing a Low Insulin Lifestyle, individuals can reduce the burden on the pancreas, promote metabolic health, and potentially mitigate the need for long-term medication dependence.